Fatal Neuroleptic Malignant Syndrome Associated with Quetiapine

American Journal of Therapeutics

Volumn 23, Issue 5, 2016, Pages e1209-e1210

  Schattner, Ami ^a,b   Kitroser, Ella ^a,b   Cohen, Joel D ^a,b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

adverse drug reaction; neuroleptic malignant syndrome; quetiapine

Indexed keywords

AMANTADINE; CARBIDOPA PLUS LEVODOPA; CEFTRIAXONE; DANTROLENE; DIAZEPAM; DIPYRONE; HALOPERIDOL; PARACETAMOL; QUETIAPINE; VALPROIC ACID; NEUROLEPTIC AGENT;

ACUTE PSYCHOSIS; AGED; ARTICLE; BRADYKINESIA; CASE REPORT; CONFUSION; CONVULSION; COOLING; DELUSION; DISORIENTATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; FEVER; HEART RATE; HEMATURIA; HOSPITAL ADMISSION; HUMAN; LEUKOCYTOSIS; LEUKOCYTURIA; MENTAL HEALTH; MULTIPLE ORGAN FAILURE; NEUROLEPTIC MALIGNANT SYNDROME; PARANOIA; PARKINSON DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RESTLESSNESS; SINGLE DRUG DOSE; TREATMENT RESPONSE; TREMOR; URINALYSIS; URINARY TRACT INFECTION; FATALITY; PATHOPHYSIOLOGY;

AGED; ANTIPSYCHOTIC AGENTS; FATAL OUTCOME; FEMALE; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSON DISEASE; QUETIAPINE FUMARATE;

EID: 84988360181     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0000000000000274     Document Type: Article

References (5)

1. Beaulieu-Boire I, Lang AE. Behavioral effects of levodopa. Mov Disord. 2015;30:90-102.
2. Gillman PK. Neuroleptic malignant syndrome: mechanisms, interactions, and causality. Mov Disord. 2010;25: 1780-1790.
3. Trollor JN, Chen X, Sachdev P. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23:477-492.
4. Detweiler MB, Sullivan K, Sharma TR, et al. Case reports of neuroleptic malignant syndrome in context of quetiapine use. Psychiatr Q. 2013;84:523-541.
5. Pringsheim T, Gardner DM. Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: A descriptive study. CMAJ Open. 2014;2:E225-E232.